KalVista Pharmaceuticals, Inc. (KALV)
20.02
-0.16
(-0.82%)
USD |
NASDAQ |
Apr 07, 11:43
KalVista Pharmaceuticals Profit Margin (Quarterly) : -8.96% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -416.2% |
| Recursion Pharmaceuticals, Inc. | -304.2% |
| Tango Therapeutics, Inc. | -- |
| Modular Medical, Inc. | -- |
| Iovance Biotherapeutics, Inc. | -82.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -282.8% |
| Return on Assets | -58.97% |
| Return on Invested Capital | -68.53% |
| Gross Profit Margin (Quarterly) | 93.36% |
| Operating Margin (Quarterly) | -19.21% |
| Return on Net Operating Assets | -980.4% |